Ascending Single Doses of Erenumab (AMG 334) in Healthy Adults and Migraine Patients

NCT01688739 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
61
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen